Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.

doi:10.1016/j.arcmed.2017.11.011

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.

Archives of medical research - 1 Aug 2017

Shi Guangjun, Wang Chuanxu, Zhang Ping, Ji Lisha, Xu Shifeng, Tan Xueying, Li Hao

Abstract excerpt

BACKGROUND: Hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) severely restricts the long-term survival of patients. Toll-like receptor 4 (TLR4) has been considered to be involved in hepatocarcinogenesis and metastasis. Additionally, there is a study demonstrating the significant association between TLR4 gene rs1927914 polymorphism and HCC, but no study investigated the association of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Kaplan-Meier Estimate

Share to Liver Neoplasms

Share to Liver Transplantation

Share to Neoplasm Recurrence, Local

Share to Risk Factors

Share to Tissue Donors

Share to Toll-Like Receptor 4

Source

Open in PubMed

Identifiers

PMID: 29221801
DOI: 10.1016/j.arcmed.2017.11.011

Genes

TLR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.PMID 29221801Read ↗

Influence of recipient KRAS gene rs712 polymorphisms on the overall survival rate of hepatocellular carcinoma after hepatic transplantation.Semantic proximity Read ↗

MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation.Semantic proximity Read ↗

Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.Semantic proximity Read ↗

Influence of recipient KRAS gene rs712 polymorphisms on the overall survival rate of Hepatocellular carcinoma after hepatic transplantationSemantic proximity Read ↗

Polymorphism in 3'-untranslated region of toll-like receptor 4 gene is associated with protection from hepatitis B virus recurrence after liver transplantation.Semantic proximity Read ↗

Recipient C7 rs9292795 genotype and the risk of hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.Semantic proximity Read ↗

Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.Semantic proximity Read ↗

Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.Semantic proximity Read ↗

Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients.Semantic proximity Read ↗

HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.Semantic proximity Read ↗

Immunological and molecular correlates of disease recurrence after liver resection for hepatocellular carcinoma.Semantic proximity Read ↗

MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.